Angiodynamics, Inc.: Clinical Trials

35 trials sponsored by Angiodynamics, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 completed, 6 not yet recruiting, 6 recruiting, 3 active not recruiting. 19 Not applicable, 6 Phase 2, 4 Phase 1, 3 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable19Completed 6, Not yet recruiting 5, Recruiting 2, Terminated 2, Unknown 2, Active not recruiting 1, Withdrawn 1
Phase 26Completed 3, Recruiting 2, Unknown 1
Phase 14Completed 3, Recruiting 1
Phase 33Recruiting 2, Active not recruiting 1
Phase 41Recruiting 1

Follow Angiodynamics, Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
AngioVac Aspiration Therapy Registry
Retrospective analysis of assigned treatment - Intracardiac Thrombus, Intracardiac Mass
Not yet recruitingCharite University, Berlin, Germany10002026-10-012026-10-20
Irreversible Electroporation (IRE) for the Treatment of Lower Urinary Tract Symptoms (LUTS) in Men With Benign Prostatic Hyperplasia (BPH)
Irreversible Electroporation - Lower Urinary Tract Symptoms (LUTS) in Men With Benign Prostatic Hyperplasia (BPH)
Not applicableNot yet recruitingAngiodynamics, Inc.402026-09-012026-06-11
Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone in Europe
Auryon Atherectomy System, Balloon Angioplasty - Peripheral Arterial Disease
Not applicableNot yet recruitingAngiodynamics, Inc.502026-05-012026-03-16
Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer
NanoKnife System, Stereotactic Body Radiation Therapy - Prostate Cancer
Phase 3RecruitingMemorial Sloan Kettering Cancer Center2242026-04-162026-09-18
Percutaneous AngioVac Vegetation Extraction (PAVE) to Remove Right Heart Vegetations in Patients With Infective Endocarditis
AngioVac System - Infective Endocarditis (IE)
Not applicableNot yet recruitingAngiodynamics, Inc.302026-04-012026-04-22
Acute Pulmonary Embolism Treatment With the AlphaVac Multipurpose Mechanical Aspiration System and the AlphaReturn Blood Management System: Evaluation of Safety and Effectiveness
AlphaReturn Blood Management System - Pulmonary Embolism Acute
Not applicableRecruitingAngiodynamics, Inc.392026-03-302026-05-11
International Study on Treatment of Liver (HCC) Patients With IRE
Irreversible Electroporation - Hepatocellular Carcinoma (HCC), Liver Ablation
Not applicableNot yet recruitingAngiodynamics, Inc.502026-02-012025-10-10
International Study on Treatment of Patients With Metastatic Colorectal Liver Lesions Patients With IRE
Irreversible Electroporation - Colorectal Adenocarcinoma Metastatic in the Liver, Liver Ablation
Not applicableNot yet recruitingAngiodynamics, Inc.502026-02-012025-10-10
Evaluating the Efficacy, Safety and Long Term Functional Outcomes of Percutaneous Mechanical Aspiration Thrombectomy for Treatment of Acute Pulmonary Embolism Using the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System
AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System - Acute Pulmonary Embolism (PE), Pulmonary Embolism
Not applicableRecruitingAngiodynamics, Inc.2562025-06-152025-09-26
Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone
Auryon Atherectomy System, Balloon Angioplasty - Peripheral Arterial Diseases
Phase 4RecruitingAngiodynamics, Inc.2242025-04-212026-01-08
COLDFIRE-III Trial: Efficacy of Irreversible Electroporation and Stereotactic Body Radiotherapy for Perivascular and Peribiliary Colorectal Liver Metastases
Irreversible electroporation, Stereotactic body radiotherapy - Colorectal Cancer, Liver Metastases
Phase 2 / Phase 3RecruitingAmsterdam UMC, location VUmc782024-08-202024-08-23
Dose Finding, Efficacy and Immunological Response of IP-001 Following MWA or IRE for CRLM
IP-001 - Colorectal Cancer, Liver Metastases
Phase 1 / Phase 2RecruitingM.R. Meijerink1202024-07-102025-07-03
Irreversible Electroporation & Pembro Immunotherapy in Locally Advanced Pancreatic Cancer
Pembrolizumab, Irreversible Electroporation - Pancreatic Cancer, Locally Advanced Pancreatic Cancer
Phase 1CompletedH. Lee Moffitt Cancer Center and Research Institute22024-04-102026-02-09
BORIS - aBlação pOR mIcro-ondaS [Microwave Ablation]
Image guided percutaneous microwave ablation - Sarcoma
Not applicableUnknownInstituto do Cancer do Estado de São Paulo602023-06-012023-08-03
Evaluating the Safety and Efficacy of the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE for Treatment of Acute Pulmonary Embolism
AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE - Pulmonary Embolism, Acute Pulmonary Embolism
Not applicableCompletedAngiodynamics, Inc.1222022-10-192024-07-19
Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue
Irreversible Electroporation - Prostate Cancer
Not applicableCompletedAngiodynamics, Inc.1212022-03-292026-06-02
Prospective, Multi-center, Single-arm Study of the Auryon Laser System for Treatment of Below-the-Knee (BTK) Arteries
Auryon Laser System - Peripheral Arterial Disease
Not applicableCompletedMidwest Cardiovascular Research Foundation602022-03-172024-11-21
Study of NanoKnife for Ablation of Prostate Cancer in Intermediate Risk Patients
NanoKnife Procedure - Prostate Cancer
Not applicableUnknownAngiodynamics, Inc.62021-05-132023-02-01
A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer
Modified FOLFIRINOX Regimen, NanoKnife System - Stage III Pancreatic Cancer
Phase 3Active not recruitingAngiodynamics, Inc.5282021-02-232025-02-12
Post-Market Registry of AURYON Atherectomy Device in Subjects Affected With Infrainguinal Peripheral Artery Disease
AURYON Atherectomy System - Infrainguinal Peripheral Artery Disease, Peripheral Arterial Disease
CompletedAngiodynamics, Inc.1022020-08-042026-05-18

Showing 20 of 35. Sign in to see all of them.

Conditions studied

Pancreatic Neoplasms (4)  ·  Peripheral Arterial Disease (4)  ·  Prostatic Neoplasms (4)  ·  Carcinoma, Hepatocellular (3)  ·  Pulmonary Embolism (3)  ·  Breast Neoplasms (2)  ·  Carcinoma, Pancreatic Ductal (2)  ·  Colorectal Neoplasms (2)  ·  Endocarditis (2)  ·  Renal Insufficiency, Chronic (2)  ·  Acute Kidney Injury (1)  ·  Arterial Occlusive Diseases (1)  ·  Bites and Stings (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Chronic Limb-Threatening Ischemia (1)

Interventions

Electroporation (8)  ·  Angioplasty, Balloon (2)  ·  Drug Delivery Systems (2)  ·  Radiosurgery (2)  ·  N-dihydrogalactochitosan (1)  ·  Radiofrequency Ablation (1)  ·  Thrombectomy (1)  ·  pembrolizumab (1)

Countries

United States (20)  ·  Netherlands (4)  ·  Germany (3)  ·  Italy (3)  ·  United Kingdom (3)  ·  Canada (2)  ·  Australia (1)  ·  Brazil (1)  ·  France (1)  ·  Poland (1)  ·  Spain (1)  ·  Switzerland (1)

Top investigators

Ajith Siriwardena, MD FRCS (2)  ·  Martijn R. Meijerink, Prof. (2)  ·  Riccardo Lencioni, MD (2)  ·  Andrew Sharp (1)  ·  Arvin George, MD (1)  ·  Christoph Starck, Prof. Dr. med. (1)  ·  Claudio Bassi, M.D. (1)  ·  Daniela Ochoa, MD (1)  ·  David Gillespie, MD (1)  ·  David Hahn, MD (1)  ·  Edward Lee, MD, PhD (1)  ·  Erik Klok (1)  ·  Himanshu Nagar, MD (1)  ·  Jonathan Coleman, MD (1)  ·  Jordi Bruix, MD (1)

Results publications

PMID 34233640, PMID 18565793, PMID 22422482, PMID 22911363, PMID 25354827, PMID 26296371, PMID 28209559, PMID 32205128, PMID 38566525

NIH funding

2023 (1)